Immuron Ltd (IMRN)
2.63
+0.20
(+8.23%)
USD |
NASDAQ |
Apr 26, 14:34
Immuron Total Assets (Quarterly): 13.55M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 13.55M |
| December 31, 2023 | 13.55M |
| June 30, 2023 | 14.55M |
| December 31, 2022 | 15.72M |
| December 31, 2022 | 15.72M |
| June 30, 2022 | 17.10M |
| December 31, 2021 | 18.40M |
| December 31, 2021 | 18.40M |
| June 30, 2021 | 20.33M |
| December 31, 2020 | 22.35M |
| December 31, 2020 | 22.35M |
| Date | Value |
|---|---|
| June 30, 2020 | 4.262M |
| December 31, 2019 | 5.861M |
| December 31, 2019 | 5.861M |
| June 30, 2019 | 5.996M |
| December 31, 2018 | 5.422M |
| December 31, 2018 | 5.422M |
| June 30, 2018 | 6.790M |
| December 31, 2017 | 4.803M |
| December 31, 2017 | 4.803M |
| June 30, 2017 | 6.368M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.262M
Minimum
Jun 2020
22.35M
Maximum
Dec 2020
14.26M
Average
15.72M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Mesoblast Ltd | 669.42M |
| CERo Therapeutics Holdings Inc | -- |
| Alterity Therapeutics Ltd | 28.76M |
| Kazia Therapeutics Ltd | 18.59M |
| Immutep Ltd | 32.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.605M |
| Shareholders Equity (Quarterly) | 11.94M |
| Current Ratio | 8.519 |